Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study

Since the completion of the KHBO1401 study, which evaluated the efficacy of the combination of gemcitabine (GEM) and cisplatin (GC) compared with GC plus S-1 (GCS), GCS has become a standard chemotherapy for patients with advanced biliary tract cancer (BTC). However, there are currently no data reve...

Descripción completa

Detalles Bibliográficos
Autores principales: Shindo, Yoshitaro, Nagano, Hiroaki, Kanai, Masashi, Kobayashi, Shogo, Wada, Hiroshi, Sakai, Daisuke, Eguchi, Hidetoshi, Baba, Hideo, Kamachi, Hirofumi, Takayama, Tadatoshi, Ueno, Masaki, Takahashi, Masahiro, Nakagami, Yuki, Yoshimura, Kenichi, Hatano, Etsuro, Ioka, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868686/
https://www.ncbi.nlm.nih.gov/pubmed/36633148
http://dx.doi.org/10.3892/or.2023.8478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868686/
https://www.ncbi.nlm.nih.gov/pubmed/36633148
http://dx.doi.org/10.3892/or.2023.8478

Ejemplares similares